These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8406169)

  • 1. Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.
    Hood KA; Gleeson D; Ruppin DC; Dowling RH
    Gut; 1993 Sep; 34(9):1277-88. PubMed ID: 8406169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term gallbladder stone recurrence and risk factors after successful lithotripsy.
    Carrilho-Ribeiro L; Pinto-Correia A; Velosa J; de Moura MC
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):209-15. PubMed ID: 10741937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
    Walters JR; Hood KA; Gleeson D; Ellul JP; Keightley A; Murphy GM; Dowling RH
    Gut; 1992 Mar; 33(3):375-80. PubMed ID: 1568659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?
    Donald JJ; Cheslyn-Curtis S; Gillams AR; Russell RC; Lees WR
    Gut; 1994 May; 35(5):692-5. PubMed ID: 8200568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gall stone dissolving agents.
    Bouchier IA
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):778-80. PubMed ID: 6402249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.
    Hussaini SH; Pereira SP; Murphy GM; Kennedy C; Wass JA; Besser GM; Dowling RH
    Gut; 1995 Jan; 36(1):126-32. PubMed ID: 7890216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallstone recurrence after successful dissolution therapy.
    Tudyka J; Wechsler JG; Kratzer W; Maier C; Mason R; Kuhn K; Adler G
    Dig Dis Sci; 1996 Feb; 41(2):235-41. PubMed ID: 8601364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.
    O'Donnell LD; Heaton KW
    Gut; 1988 May; 29(5):655-8. PubMed ID: 3396952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimum bile acid treatment for rapid gall stone dissolution.
    Jazrawi RP; Pigozzi MG; Galatola G; Lanzini A; Northfield TC
    Gut; 1992 Mar; 33(3):381-6. PubMed ID: 1568660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group.
    Petroni ML; Jazrawi RP; Pazzi P; Zuin M; Lanzini A; Fracchia M; Facchinetti D; Alvisi V; Ferraris R; Bland JM; Heaton KW; Podda M; Northfield TC
    Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):695-700. PubMed ID: 10912491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
    van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
    Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution of gall stones with an ursodeoxycholic acid menthol preparation: a controlled prospective double blind trial.
    Leuschner M; Leuschner U; Lazarovici D; Kurtz W; Hellstern A
    Gut; 1988 Apr; 29(4):428-32. PubMed ID: 3286383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.
    Boscaini M; Piccinni-Leopardi M; Andreotti F; Montori A
    Gut; 1994 Jan; 35(1):117-21. PubMed ID: 8307431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early results of combined electrohydraulic shock-wave lithotripsy and oral litholytic therapy of gallbladder stones at the University of Iowa.
    Maher JW; Summers RW; Dean TR; Swift J; Heitshusen D; Quinn G
    Surgery; 1990 Oct; 108(4):648-52; discussion 653-4. PubMed ID: 2218875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography in predicting gall stone solubility: a prospective trial.
    Caroli A; Del Favero G; Di Mario F; Spigariol F; Scalon P; Meggiato T; Zambelli C; Naccarato R
    Gut; 1992 May; 33(5):698-700. PubMed ID: 1612490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholelithiasis and acromegaly: therapeutic strategies.
    Montini M; Gianola D; Pagani MD; Pedroncelli A; Caldara R; Gherardi F; Bonelli M; Lancranjan I; Pagani G
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):401-6. PubMed ID: 8187305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid for the dissolution of radiolucent gall bladder stones.
    Neligan P; Bateson MC; Trash DB; Ross PE; Bouchier IA
    Digestion; 1983; 28(4):225-33. PubMed ID: 6671484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.